Cannabinoid Regulation of Nitric Oxide Synthase I (nNOS) in Neuronal Cells

被引:0
作者
Skyla T. Carney
Michael L. Lloyd
Shanta E. MacKinnon
Doshandra C. Newton
Jenelle D. Jones
Allyn C. Howlett
Derek C. Norford
机构
[1] North Carolina Central University,Neuroscience of Drug Abuse Research Program, Julius L. Chambers Biomedical/Biotechnology Research Institute
[2] Wake Forest University Health Sciences,Department of Physiology and Pharmacology
来源
Journal of Neuroimmune Pharmacology | 2009年 / 4卷
关键词
CB; cannabinoid receptor; CP55940; nitric oxide; gene expression; G-protein coupled receptors; G-proteins; neuronal nitric oxide synthase; methanandamide; 2-arachidonoylglycerol; real-time polymerase chain reaction; rimonabant (SR141716); WIN55212-2;
D O I
暂无
中图分类号
学科分类号
摘要
In our previous studies, CB1 cannabinoid receptor agonists stimulated production of cyclic GMP and translocation of nitric oxide (NO)-sensitive guanylyl cyclase in neuronal cells (Jones et al., Neuropharmacology 54:23–30, 2008). The purpose of these studies was to elucidate the signal transduction of cannabinoid-mediated neuronal nitric oxide synthase (nNOS) activation in neuronal cells. Cannabinoid agonists CP55940 (2-[(1S,2R,5S)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-5-(2-methyloctan-2-yl)phenol), WIN55212-2 (R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate), and the metabolically stable analog of anandamide, (R)-(+)-methanandamide stimulated NO production in N18TG2 cells over a 20-min period. Rimonabant (N-(piperidin-lyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-H-pyrazole-3-carboxamide), a CB1 receptor antagonist, partially or completely curtailed cannabinoid-mediated NO production. Inhibition of NOS activity (NG-nitro-l-arginine) or signaling via Gi/o protein (pertussis toxin) significantly limited NO production by cannabinoid agonists. Ca2+ mobilization was not detected in N18TG2 cells after cannabinoid treatment using Fluo-4 AM fluorescence. Cannabinoid-mediated NO production was attributed to nNOS activation since endothelial NOS and inducible NOS protein and mRNA were not detected in N18TG2 cells. Bands of 160 and 155 kDa were detected on Western blot analysis of cytosolic and membrane fractions of N18TG2 cells, using a nNOS antibody. Chronic treatment of N18TG2 cells with cannabinoid agonists downregulated nNOS protein and mRNA as detected using Western blot analysis and real-time polymerase chain reaction, respectively. Cannabinoid agonists stimulated NO production via signaling through CB1 receptors, leading to activation of Gi/o protein and enhanced nNOS activity. The findings of these studies provide information related to cannabinoid-mediated NO signal transduction in neuronal cells, which has important implications in the ongoing elucidation of the endocannabinoid system in the nervous system.
引用
收藏
页码:338 / 349
页数:11
相关论文
共 320 条
[21]  
Tenu JP(1999)Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta actin genes as internal standard for quantative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulation FEBS Lett 459 277-281
[22]  
Bradford MM(1997)Endogenous expression of nNOS protein in several neuronal cell lines Trends Neurosci 20 298-303
[23]  
Bredt DS(2002)Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity Pharmacol Rev 54 161-202
[24]  
Hwang PM(1997)Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity Curr Biol 7 R141-R143
[25]  
Glatt CE(2006)International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Nitric Oxide 15 13-19
[26]  
Lowenstein C(1999)Synaptic plasticity: a role for nitric oxide in LTP J Biol Chem 274 17559-17566
[27]  
Reed RR(2008)Expression of neuronal nitric oxide synthase variant, nNOS-μ, in rat brain Neuropharmacology 54 23-30
[28]  
Snyder SH(1999)Characterization of mouse nNOS2, a natural variant of neuronal nitric-oxide synthase produced in the central nervous system by selective alternative splicing J Neurosci 19 4544-4558
[29]  
Bredt DS(2006)Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells Mol Pharmacol 69 691-696
[30]  
Ferris CD(1994)Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons Biochem J 298 249-258